Sun Pharma Advanced Research Company Ltd

SPARC Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sun Pharma Advanced Research Company Ltd

₹ 151 -6.02%
03 Dec 3:11 p.m.
sparc.life BSE: 532872 NSE: SPARC
About

Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.[1]

Key Points

Leadership[1]
First listed pharma R&D company out of India where founders still own 70% and continue to invest.

Website BSE NSE
  • Market Cap ₹ 4,913 Cr.
  • Current Price ₹ 151
  • High / Low ₹ 241 / 109
  • Stock P/E
  • Book Value ₹ -10.6
  • Dividend Yield 0.00 %
  • ROCE -279 %
  • ROE %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last 3 years: -3.42%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
48 24 21 14 17 17 13 15 27 10 8
137 126 113 116 122 110 116 89 80 62 74
Operating Profit -90 -102 -91 -103 -106 -93 -103 -74 -53 -52 -66
OPM % -188% -427% -432% -740% -639% -555% -800% -494% -196% -540% -836%
11 10 8 6 4 2 0 0 0 9 0
Interest 0 0 0 0 1 1 1 3 5 6 8
Depreciation 3 3 3 3 3 3 3 3 3 3 3
Profit before tax -82 -95 -86 -100 -105 -96 -107 -79 -61 -52 -76
Tax % 0% 0% 0% 0% 0% 0% 0% 0% -1% 0% 0%
-82 -95 -86 -100 -106 -96 -107 -80 -60 -52 -76
EPS in Rs -2.53 -2.94 -2.66 -3.07 -3.26 -2.96 -3.31 -2.45 -1.84 -1.60 -2.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 TTM
239 76 72 60
453 478 395 304
Operating Profit -214 -402 -323 -245
OPM % -90% -532% -450% -411%
11 29 2 9
Interest 8 2 9 21
Depreciation 12 13 12 11
Profit before tax -223 -387 -343 -268
Tax % 0% 0% -0%
-223 -387 -343 -267
EPS in Rs -6.86 -11.93 -10.55 -8.23
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 35%
Stock Price CAGR
10 Years: -8%
5 Years: -3%
3 Years: -14%
1 Year: -26%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 32 32 32 32
Reserves 480 93 -249 -377
16 61 269 417
302 328 284 250
Total Liabilities 830 515 336 322
106 108 99 162
CWIP 27 44 54 1
Investments 291 2 0 0
406 362 183 160
Total Assets 830 515 336 322

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
-69 -429 -360
-548 392 158
617 42 199
Net Cash Flow -1 5 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 50 75 82
Inventory Days
Days Payable
Cash Conversion Cycle 50 75 82
Working Capital Days -193 -738 -1,780
ROCE % -108% -279%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
68.23% 65.68% 65.68% 65.68% 65.68% 65.68% 65.68% 65.68% 65.68% 65.68% 65.67% 65.67%
3.48% 3.64% 3.64% 3.67% 3.30% 3.24% 2.64% 2.15% 2.23% 1.45% 1.47% 1.76%
0.76% 0.63% 0.63% 0.65% 0.67% 0.67% 0.17% 0.21% 0.64% 1.13% 0.97% 1.05%
27.53% 30.04% 30.06% 29.99% 30.36% 30.41% 31.51% 31.96% 31.47% 31.76% 31.88% 31.52%
No. of Shareholders 96,33798,7771,00,8071,01,4331,03,9901,02,7431,25,1841,28,2051,31,0341,42,8641,40,7241,36,997

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls